BIVI
Price
$1.59
Change
-$0.16 (-9.14%)
Updated
Aug 19 closing price
Capitalization
11.89M
HMTXF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Aug 19 closing price
Capitalization
9.98M
Interact to see
Advertisement

BIVI vs HMTXF

Header iconBIVI vs HMTXF Comparison
Open Charts BIVI vs HMTXFBanner chart's image
BioVie
Price$1.59
Change-$0.16 (-9.14%)
Volume$329.11K
Capitalization11.89M
Hemostemix
Price$0.06
Change-$0.00 (-0.00%)
Volume$350
Capitalization9.98M
BIVI vs HMTXF Comparison Chart in %
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. HMTXF commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and HMTXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (BIVI: $1.59 vs. HMTXF: $0.06)
Brand notoriety: BIVI and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 124% vs. HMTXF: 2%
Market capitalization -- BIVI: $11.89M vs. HMTXF: $9.98M
BIVI [@Biotechnology] is valued at $11.89M. HMTXF’s [@Biotechnology] market capitalization is $9.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.19B to $0. The average market capitalization across the [@Biotechnology] industry is $1.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, HMTXF is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 4 TA indicator(s) are bullish while HMTXF’s TA Score has 4 bullish TA indicator(s).

  • BIVI’s TA Score: 4 bullish, 4 bearish.
  • HMTXF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BIVI is a better buy in the short-term than HMTXF.

Price Growth

BIVI (@Biotechnology) experienced а -4.79% price change this week, while HMTXF (@Biotechnology) price change was -2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.66%. For the same industry, the average monthly price growth was +26.06%, and the average quarterly price growth was +20.46%.

Industries' Descriptions

@Biotechnology (+2.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIVI($11.9M) has a higher market cap than HMTXF($9.99M). HMTXF YTD gains are higher at: -22.563 vs. BIVI (-92.050). HMTXF has higher annual earnings (EBITDA): -2.79M vs. BIVI (-16.98M). BIVI has more cash in the bank: 17.5M vs. HMTXF (965K). BIVI has less debt than HMTXF: BIVI (350K) vs HMTXF (4.69M). BIVI (0) and HMTXF (0) have equivalent revenues.
BIVIHMTXFBIVI / HMTXF
Capitalization11.9M9.99M119%
EBITDA-16.98M-2.79M609%
Gain YTD-92.050-22.563408%
P/E RatioN/AN/A-
Revenue00-
Total Cash17.5M965K1,813%
Total Debt350K4.69M7%
FUNDAMENTALS RATINGS
BIVI vs HMTXF: Fundamental Ratings
BIVI
HMTXF
OUTLOOK RATING
1..100
5059
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9965
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HMTXF's Valuation (4) in the null industry is in the same range as BIVI (11). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

HMTXF's Profit vs Risk Rating (100) in the null industry is in the same range as BIVI (100). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

BIVI's SMR Rating (99) in the null industry is in the same range as HMTXF (100). This means that BIVI’s stock grew similarly to HMTXF’s over the last 12 months.

HMTXF's Price Growth Rating (65) in the null industry is somewhat better than the same rating for BIVI (99). This means that HMTXF’s stock grew somewhat faster than BIVI’s over the last 12 months.

HMTXF's P/E Growth Rating (100) in the null industry is in the same range as BIVI (100). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIVIHMTXF
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 28 days ago
83%
Bullish Trend 26 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKWAD34.70N/A
N/A
ROCKWOOL A S
TNEYF3.83-0.06
-1.49%
Tamarack Valley Energy, Ltd.
MUNMF0.16N/A
-1.99%
Mundoro Capital, Inc.
QNCCF0.72-0.02
-3.35%
Quantum eMotion Corp.
AFSIP14.61-1.76
-10.72%
AmTrust Financial Services, Inc.

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-9.14%
HURA - BIVI
45%
Loosely correlated
-2.91%
THAR - BIVI
35%
Loosely correlated
-10.00%
JBPHF - BIVI
31%
Poorly correlated
N/A
LGVN - BIVI
31%
Poorly correlated
+2.32%
CMND - BIVI
30%
Poorly correlated
-1.96%
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and SLRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
+3.02%
SLRX - HMTXF
30%
Poorly correlated
-15.27%
AZTR - HMTXF
26%
Poorly correlated
-1.79%
CTXR - HMTXF
24%
Poorly correlated
-10.87%
BIVI - HMTXF
21%
Poorly correlated
-9.14%
DVHGF - HMTXF
21%
Poorly correlated
N/A
More